Market revenue in 2023 | USD 312.6 million |
Market revenue in 2030 | USD 543.5 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.1% in 2023. Horizon Databook has segmented the Kuwait drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
The drug-device combination products market in Kuwait is growing due to several important factors. One key factor is the increasing need for advanced drug-device combination solutions due to the rising number of surgical procedures related to heart & lung transplants. Kuwait's focus on adopting sophisticated medical technologies is fueling the demand for effective agents to manage respiratory failure conditions in the country.
In addition, the market expansion is influenced by the growing prevalence of chronic diseases and the continuous advancement of medical devices. As per a study published in 2020, the prevalence of COPD was 7.1% in Kuwait, and the hospitalization rate was 22.5%. According to the data published by a Karger journal, in December 2022, 25% of individuals in Kuwait reported having at least one NCD.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account